Kristen Hege insider trades

Open-market stock purchases and sales by Kristen Hege, Director at Mersana Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2018.

Recent trades

DateStockTradeValue
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$22.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$61.7K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$123K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$108K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$60.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$211K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$53.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$373K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$67K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$163K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$14.7K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$159K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$12.5K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$12K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$14.6K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$124K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$214K

Companies traded

  • MRSN Mersana Therapeutics, Inc: other filings, last Jan 6, 2026
  • ADAP Adaptimmune Therapeutics plc: other filings, last Jul 1, 2024
  • GRPH Graphite Bio, Inc: other filings, last Jul 19, 2023
  • RCUS Arcus Biosciences, Inc: other filings, last Jun 6, 2019

Get free alerts when Kristen Hege files a new trade →